Blood biomarker shows ‘great promise’ predicting progression to Alzheimer’s disease in at-risk population

Neuroscience researchers at Wayne State University published a review article that confirms the usefulness of neurofilament light (NfL) blood levels to predict the likelihood and rate of progression of neurodegeneration in Alzheimer’s disease. The review article, «The Potential of Blood Neurofilament Light as a Marker of Neurodegeneration in Alzheimer’s disease,» is published in the journal Brain.